Journal of Clinical Toxicology
Open Access
ISSN: 2161-0495
ISSN: 2161-0495
Department of Cerebrovascular Diseases, Luzhou People's Hospital, Sichuan, China
Research Article
A Systematic Review and Meta-Analysis of RCT-Based WangBi-Components for the Treatment of Rheumatoid Arthritis
Author(s): Li Yang, Yanwei He, Nana Xu, Bo Yu, Min Tang and Mishan Wu*
Objective: To evaluate efficacy and safety of WangBi Components (WBC) in the treatment of Rheumatoid Arthritis (RA) using systematic and meta-analysis technique.
Methods: Potentially eligible studies were found from PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), VIP Database for Chinese Technical Periodicals, Wanfang Database on Academic Institutions in China, Chinese Medical Journal Full-text Database, ClinicalTrials.gov and EBSCOhost by a search strategy including the terms "WangBi" and "rheumatoid arthritis" from inception to September 23, 2024. Eligible randomized controlled trials must consist of one group of treatment regimens containing WBC and another group without WBC. Two reviewers independently evaluated the quality of the included studies and extracted materials for bias risk assessmen.. View More»